Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2022 | 1672 | 1.550 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2020 | 131 | 1.440 |
Why?
|
| Calcium | 19 | 2020 | 5792 | 1.330 |
Why?
|
| Fasting | 3 | 2024 | 1607 | 1.170 |
Why?
|
| Gastrointestinal Contents | 2 | 2024 | 42 | 1.130 |
Why?
|
| Sepsis | 6 | 2022 | 2605 | 1.110 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 243 | 1.110 |
Why?
|
| Endotoxemia | 3 | 2017 | 198 | 1.020 |
Why?
|
| Tachyphylaxis | 1 | 2024 | 54 | 0.920 |
Why?
|
| Sodium-Calcium Exchanger | 7 | 2013 | 90 | 0.830 |
Why?
|
| Gastroparesis | 1 | 2023 | 143 | 0.720 |
Why?
|
| Myocardium | 11 | 2019 | 4765 | 0.710 |
Why?
|
| Cardiomyopathies | 3 | 2017 | 2057 | 0.660 |
Why?
|
| Myocardial Contraction | 7 | 2021 | 1516 | 0.620 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 3 | 2017 | 185 | 0.620 |
Why?
|
| Respiratory Tract Diseases | 1 | 2024 | 744 | 0.620 |
Why?
|
| Hypoglycemic Agents | 5 | 2024 | 3108 | 0.610 |
Why?
|
| Lipopolysaccharides | 4 | 2022 | 2217 | 0.570 |
Why?
|
| Anesthesia | 5 | 2024 | 1595 | 0.540 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2017 | 164 | 0.530 |
Why?
|
| Perioperative Care | 1 | 2024 | 1043 | 0.530 |
Why?
|
| Shock, Septic | 1 | 2022 | 772 | 0.520 |
Why?
|
| Heart Diseases | 3 | 2022 | 2817 | 0.490 |
Why?
|
| Intraoperative Complications | 3 | 2011 | 1171 | 0.460 |
Why?
|
| Heart | 6 | 2017 | 4429 | 0.390 |
Why?
|
| Cardiomegaly | 1 | 2015 | 591 | 0.390 |
Why?
|
| Anesthetics | 1 | 2017 | 525 | 0.370 |
Why?
|
| Calcium Channels | 4 | 2019 | 622 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 12250 | 0.360 |
Why?
|
| Sarcomeres | 3 | 2019 | 379 | 0.340 |
Why?
|
| Reactive Oxygen Species | 3 | 2022 | 2144 | 0.330 |
Why?
|
| Mitochondria, Heart | 2 | 2021 | 229 | 0.330 |
Why?
|
| Guanylate Cyclase | 3 | 2016 | 206 | 0.300 |
Why?
|
| Up-Regulation | 1 | 2017 | 4143 | 0.300 |
Why?
|
| Anabolic Agents | 1 | 2010 | 256 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 2144 | 0.290 |
Why?
|
| Nickel | 4 | 2000 | 126 | 0.280 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2024 | 888 | 0.280 |
Why?
|
| Infarction | 1 | 2008 | 247 | 0.270 |
Why?
|
| Atrioventricular Block | 1 | 2008 | 141 | 0.270 |
Why?
|
| Trachea | 1 | 2012 | 1095 | 0.270 |
Why?
|
| Coloring Agents | 1 | 2008 | 565 | 0.260 |
Why?
|
| Membrane Potentials | 5 | 2004 | 1085 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1965 | 0.250 |
Why?
|
| Cyclic AMP | 3 | 2000 | 1472 | 0.250 |
Why?
|
| Cytokines | 2 | 2022 | 7446 | 0.230 |
Why?
|
| Thiourea | 1 | 2004 | 68 | 0.230 |
Why?
|
| Respiratory Aspiration | 1 | 2024 | 89 | 0.220 |
Why?
|
| Androgens | 1 | 2010 | 1281 | 0.210 |
Why?
|
| Calcium Channel Blockers | 4 | 2000 | 688 | 0.210 |
Why?
|
| Heart Rate | 2 | 2011 | 4209 | 0.200 |
Why?
|
| Cadmium | 3 | 1999 | 218 | 0.200 |
Why?
|
| Calcium Signaling | 2 | 2020 | 736 | 0.200 |
Why?
|
| Preoperative Period | 1 | 2024 | 564 | 0.190 |
Why?
|
| Glucagon-Like Peptides | 1 | 2023 | 157 | 0.190 |
Why?
|
| Endoscopy, Digestive System | 1 | 2024 | 358 | 0.190 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 540 | 0.180 |
Why?
|
| Animals | 23 | 2022 | 168965 | 0.180 |
Why?
|
| Peptides | 4 | 2004 | 4348 | 0.180 |
Why?
|
| Electrocardiography | 2 | 2011 | 6409 | 0.180 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2021 | 91 | 0.170 |
Why?
|
| Spinal Cord | 1 | 2008 | 1811 | 0.170 |
Why?
|
| Sarcolemma | 1 | 1999 | 66 | 0.170 |
Why?
|
| Sodium | 4 | 2004 | 1594 | 0.170 |
Why?
|
| Cyclooxygenase 1 | 1 | 2019 | 98 | 0.160 |
Why?
|
| Catalase | 1 | 2019 | 215 | 0.160 |
Why?
|
| Cecum | 1 | 2019 | 231 | 0.150 |
Why?
|
| Ligation | 1 | 2019 | 446 | 0.150 |
Why?
|
| Ion Transport | 3 | 2004 | 322 | 0.150 |
Why?
|
| Punctures | 1 | 2019 | 371 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 22361 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 597 | 0.140 |
Why?
|
| Male | 20 | 2024 | 364203 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 856 | 0.140 |
Why?
|
| Action Potentials | 3 | 2003 | 1835 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2001 | 0.130 |
Why?
|
| Models, Animal | 1 | 2022 | 2121 | 0.130 |
Why?
|
| Guinea Pigs | 5 | 2003 | 1309 | 0.130 |
Why?
|
| Heart Failure | 5 | 2020 | 11877 | 0.130 |
Why?
|
| Mice | 8 | 2022 | 81912 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1997 | 479 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.120 |
Why?
|
| Endoscopy | 1 | 2024 | 1854 | 0.110 |
Why?
|
| Dogs | 4 | 2004 | 3834 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 1243 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2022 | 2493 | 0.110 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2004 | 881 | 0.110 |
Why?
|
| Cells, Cultured | 7 | 2020 | 18989 | 0.110 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18330 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2024 | 41718 | 0.100 |
Why?
|
| Humans | 22 | 2024 | 767040 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3139 | 0.100 |
Why?
|
| Heart Ventricles | 4 | 2003 | 3837 | 0.100 |
Why?
|
| Risk | 1 | 2024 | 9606 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2013 | 394 | 0.100 |
Why?
|
| Tracheal Neoplasms | 1 | 2012 | 124 | 0.100 |
Why?
|
| Rabbits | 4 | 1999 | 4751 | 0.090 |
Why?
|
| Weight Loss | 1 | 2023 | 2716 | 0.090 |
Why?
|
| Postoperative Complications | 3 | 2024 | 15824 | 0.090 |
Why?
|
| Tracheal Stenosis | 1 | 2012 | 228 | 0.090 |
Why?
|
| Female | 10 | 2024 | 396660 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2906 | 0.090 |
Why?
|
| Bradycardia | 1 | 2011 | 305 | 0.080 |
Why?
|
| Ion Channel Gating | 2 | 2004 | 428 | 0.080 |
Why?
|
| Intraoperative Care | 1 | 2012 | 768 | 0.080 |
Why?
|
| Ephedrine | 1 | 2008 | 52 | 0.080 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 58 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 1081 | 0.080 |
Why?
|
| Cysteine | 1 | 2013 | 896 | 0.080 |
Why?
|
| Adrenergic Agents | 1 | 2008 | 72 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2008 | 128 | 0.080 |
Why?
|
| Metoprolol | 1 | 2008 | 90 | 0.080 |
Why?
|
| Propanolamines | 1 | 2008 | 164 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 8108 | 0.070 |
Why?
|
| Caffeine | 2 | 2004 | 703 | 0.070 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 135 | 0.070 |
Why?
|
| Airway Obstruction | 1 | 2012 | 672 | 0.070 |
Why?
|
| Midazolam | 1 | 2008 | 267 | 0.070 |
Why?
|
| Paralysis | 1 | 2008 | 250 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 1997 | 405 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 2 | 1999 | 924 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2012 | 1480 | 0.070 |
Why?
|
| Echocardiography | 2 | 2016 | 5042 | 0.060 |
Why?
|
| Blood Pressure | 3 | 2011 | 8531 | 0.060 |
Why?
|
| Middle Aged | 7 | 2024 | 223233 | 0.060 |
Why?
|
| Anesthetics, Intravenous | 1 | 2008 | 396 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 888 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2000 | 1736 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 947 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 857 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 1359 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9513 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 122 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2004 | 62 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2012 | 2252 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2009 | 709 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1836 | 0.050 |
Why?
|
| Exercise Test | 1 | 2011 | 2188 | 0.050 |
Why?
|
| Ventricular Remodeling | 2 | 2021 | 1281 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2020 | 1751 | 0.050 |
Why?
|
| Propofol | 1 | 2008 | 608 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7868 | 0.050 |
Why?
|
| Tachycardia | 1 | 2004 | 598 | 0.050 |
Why?
|
| Aged | 6 | 2024 | 171319 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2004 | 538 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 404 | 0.050 |
Why?
|
| Electrophysiology | 2 | 2001 | 1263 | 0.050 |
Why?
|
| Buffers | 1 | 2000 | 141 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2000 | 102 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2008 | 1786 | 0.040 |
Why?
|
| Oxidants | 1 | 2020 | 168 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81659 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 1931 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 213 | 0.040 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 242 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 1331 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 911 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2004 | 1195 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2004 | 1080 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 2009 | 2140 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 3934 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14476 | 0.040 |
Why?
|
| Adult | 6 | 2024 | 223317 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 740 | 0.030 |
Why?
|
| Biological Transport | 2 | 1997 | 2084 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 694 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 59548 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 65295 | 0.030 |
Why?
|
| Kinetics | 1 | 2000 | 6287 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13411 | 0.030 |
Why?
|
| Rats | 2 | 1999 | 23713 | 0.030 |
Why?
|
| Cell Membrane | 2 | 1999 | 3642 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17608 | 0.020 |
Why?
|
| Time Factors | 3 | 2010 | 40154 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1996 | 871 | 0.020 |
Why?
|
| Models, Biological | 2 | 2004 | 9464 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11513 | 0.020 |
Why?
|
| Risk Factors | 3 | 2024 | 74886 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3726 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39317 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1928 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 10748 | 0.020 |
Why?
|
| Lupus Vulgaris | 1 | 1968 | 10 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 210 | 0.020 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 1968 | 17 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 2257 | 0.020 |
Why?
|
| Endotoxins | 1 | 2009 | 519 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1168 | 0.010 |
Why?
|
| Research Design | 1 | 1999 | 6210 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3587 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11923 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 89046 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2002 | 24 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 1965 | 252 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2002 | 52 | 0.010 |
Why?
|
| Caveolins | 1 | 2002 | 102 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 398 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 175 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1996 | 5914 | 0.010 |
Why?
|
| Encephalitis | 1 | 1965 | 441 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 345 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 513 | 0.010 |
Why?
|
| Dialysis Solutions | 1 | 1999 | 33 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 706 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6513 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4349 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 1688 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2350 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 30211 | 0.010 |
Why?
|
| Gap Junctions | 1 | 1997 | 230 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2478 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1996 | 956 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9551 | 0.010 |
Why?
|
| Epilepsy | 1 | 1965 | 3317 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 2114 | 0.000 |
Why?
|
| Cholesterol | 1 | 1996 | 2905 | 0.000 |
Why?
|
| Linear Models | 1 | 1996 | 5875 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1997 | 4925 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2002 | 23621 | 0.000 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_